Global Orthopedics Market 2021: Leading Supplier Strategies, Marketing Tactics, and Technological Know How
This report provides a worldwide strategic overview of the orthopedics market, including forecasts for major geographic regions, market segments and product categories.
In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc.
The analysis of major market segments, including reconstructive devices, fracture fixation products, arthroscopy, soft tissue repair, spinal implants and instrumentation, bone growth stimulators, power instruments, casting materials, operating room ancillary products and others is provided, as well as a review of the major geographic regions, including U.S., Europe, Japan/Pacific and others.
The company profiles include:
In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc.
The analysis of major market segments, including reconstructive devices, fracture fixation products, arthroscopy, soft tissue repair, spinal implants and instrumentation, bone growth stimulators, power instruments, casting materials, operating room ancillary products and others is provided, as well as a review of the major geographic regions, including U.S., Europe, Japan/Pacific and others.
The company profiles include:
- Business, new product development and marketing strategies.
- Anticipated acquisitions and joint ventures.
- Major strengths and weaknesses.
- The U.S. and international sales force size.
- Distribution approaches.
- Major promotional tactics.
- Internally developed and acquired technologies.
- Technical expertise in biotechnology, engineering and other pertinent fields.
I. MARKET OVERVIEW
A. U.S.A
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Industry Consolidation
d. Managed Care
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Population Aging
B. Other Countries
II. MARKET SIZE AND GROWTH
a. Major Market Segments
b. Major Geographic Regions
III. EMERGING TECHNOLOGIES
a. Overview
b. Resorbables
c. Bone Substitutes
d. Osteoinductive Agents/Bone Graft Factors
e. Soft Tissue Repair And Replacement
f. Viscoelastics
g. Osteoporosis Therapies
IV. LEADING ORTHOPEDICS COMPANIES STRATEGIC DIRECTIONS
Business, new product development and marketing strategies
Anticipated acquisitions, joint ventures and marketing strategies
Major strengths and weaknesses
V. LEADING ORTHOPEDICS COMPANIES MARKETING TACTICS
The U.S. and international sales force size
Distribution approaches
Major promotional tactics
VI. LEADING ORTHOPEDICS COMPANIES TECHNOLOGICAL KNOW-HOW
Internally developed and acquired technologies
Technical expertise in biotechnology, engineering and other pertinent fields
A. U.S.A
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Industry Consolidation
d. Managed Care
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Population Aging
B. Other Countries
II. MARKET SIZE AND GROWTH
a. Major Market Segments
b. Major Geographic Regions
III. EMERGING TECHNOLOGIES
a. Overview
b. Resorbables
c. Bone Substitutes
d. Osteoinductive Agents/Bone Graft Factors
e. Soft Tissue Repair And Replacement
f. Viscoelastics
g. Osteoporosis Therapies
IV. LEADING ORTHOPEDICS COMPANIES STRATEGIC DIRECTIONS
Business, new product development and marketing strategies
Anticipated acquisitions, joint ventures and marketing strategies
Major strengths and weaknesses
V. LEADING ORTHOPEDICS COMPANIES MARKETING TACTICS
The U.S. and international sales force size
Distribution approaches
Major promotional tactics
VI. LEADING ORTHOPEDICS COMPANIES TECHNOLOGICAL KNOW-HOW
Internally developed and acquired technologies
Technical expertise in biotechnology, engineering and other pertinent fields
